Spatial biology at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
19 organizations at FoG London 2027 present work in spatial biology: 10 suppliers and service providers, 8 universities and research institutes and 1 drug or crop developer. Between them they bring 66 presentations to the program. Most represented: UCL (15 on the program), University of Cambridge (10 on the program), Wellcome Sanger Institute (10 on the program). As of Oct 29, 2026.
Format
Top represented
Showing 1–5 of 19 organizations
| Organization | FoG London 2027 Attendance |
|---|---|
UCL London, UK | |
Multidisciplinary London research university with faculties of medical, life, brain and population health sciences, including the Great Ormond Street Institute of Child Health. | Talk Wed Jan 27 11:30–12:00 What Do We Need to Get More Advanced Therapies to Patients? How regulatory changes in the US, UK and EU, plus practical rollout models, could bring more advanced therapies to patients. Talk Wed Jan 27 12:30–13:00 Quantitative Proteomics to Unravel Signaling in Rare Cells How mapping protein phosphorylation in just hundreds of cells reveals dormant, drug-resistant glioblastoma cells and leftover disease in acute myeloid leukaemia. Talk Wed Jan 27 14:30–15:00 Resolving RNA Diversity in Neurodegenerative Disease: From Mechanism to Therapeutic Targeting How large human brain RNA datasets link disease-associated genetic variants to genes and mechanisms in Lewy body disorders and related neurodegenerative diseases. Talk Wed Jan 27 15:30–16:00 Tracing Metastatic Evolution with Spatial Biology: Insights for Immunity and Immune Evasion How mapping cells in place across primary tumours and their metastases reveals the earliest steps of cancer spread and immune escape. Talk Wed Jan 27 15:30–16:00 Why Does the Food Environment Affect Us Differently? What it means to call obesity genetic, how genes and food surroundings interact to shape weight, and what a twin study shows. Population & social genomics Talk Wed Jan 27 16:30–17:00 Personalised Surveillance in Ovarian Cancer: Does It Work? Whether tracking a blood tumour marker over time helps women at high genetic risk of ovarian cancer who are awaiting preventive surgery. Talk Wed Jan 27 16:30–17:00 Why Do We Age So DIfferently? Why people with similar genes and lifestyles age at different rates, and what genetically identical organisms reveal about chance in ageing. Population & social genomics Talk Thu Jan 28 10:30–11:00 Who Do We Think We Are? What the Last Decade of Genomics Has Revealed About Us What ancient DNA has revealed about human migration and ancestry, and what genetics can and cannot say about race and identity. Population & social genomics Talk Thu Jan 28 11:30–12:00 Ageing as a Modifiable Process: From Lifestyle to Therapeutic Intervention How exercise, sleep, diet and social life shape ageing, and whether existing drugs could target ageing biology to delay disease. Talk Thu Jan 28 11:30–12:00 Talk Thu Jan 28 12:30–13:00 Rewriting the Rules: Gene Therapy and Clinical Trials in Pregnancy Why pregnant women were long excluded from clinical trials, how pregnancy research can now run safely, and what fetal gene therapy could offer. Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics Talk Thu Jan 28 16:10–16:40 25 Years of Gene Therapy for Inherited Immune Disorders: Progress and Future Potential How gene and cell therapies are moving from experiments toward potential cures for inherited blood diseases and cancer, and what blocks wider access. Talk Thu Jan 28 16:10–16:40 Critical Appraisal of Polygenic Risk Scores and Circulating Proteins for Screening, Risk Stratification and Individual Risk Prediction How to judge whether polygenic risk scores and blood protein markers really help with screening, risk grouping and predicting individual disease risk. Talk Thu Jan 28 16:40–17:10 From Research to Reality: Ensuring Women Benefit from Innovation How to design women's health tests and technologies that work for all women, and who risks being left behind by them. |
University of Cambridge Cambridge, UK | |
Collegiate research university in Cambridge, England, whose School of Clinical Medicine sits on the Cambridge Biomedical Campus beside Addenbrooke's Hospital. | Talk Wed Jan 27 11:30–12:00 Integrating Spatial Multi-Omics: From Technology Development to Biological Discovery How combining RNA and protein maps of tissue shows how ovarian tumour cells interact with immune cells across body sites and tumour types. Talk Wed Jan 27 11:30–12:00 Preeclampsia and Fetal Growth Restriction: From Prediction to Prevention How tracking proteins, RNA and metabolites through pregnancy could flag placental problems like preeclampsia and fetal growth restriction before symptoms appear. Talk Wed Jan 27 15:30–16:00 Tracking the Emergence and Spread of Antimicrobial Resistance Through Bacterial Genomics How building family trees from bacterial genomes dates the rise of drug-resistant strains, measures policy effects and traces hospital outbreaks. Talk Wed Jan 27 16:30–17:00 Beyond Single-Gene Testing: Using Polygenic Risk to Guide Precision Treatment How a person's overall genetic profile, not single genes, could show who benefits most from diabetes and high blood pressure treatments. Talk Wed Jan 27 17:30–18:00 From Stem Cell States to Stem Cell Flux: Navigating Cellular Landscapes Using scRNA Seq How single-cell RNA sequencing and computer models reconstruct the paths stem cells take as they change and choose their fates. Talk Wed Jan 27 17:30–18:00 Using AI and Spatial Multiomics to Decode Tumour Evolution and Identify High-Risk Cancer Why cancers with similar genetic drivers behave so differently, and how AI applied to maps of tumour tissue could flag aggressive cancers earlier. Talk Thu Jan 28 08:45–09:15 Why Are We Hungry? What Genomics Is Revealing About Appetite and Obesity What rare genetic cases, population studies and cell-by-cell brain maps reveal about the biology of appetite and obesity. Single-cell genomicsPopulation & social genomics Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics Talk Thu Jan 28 15:10–15:40 Beyond Polygenic Risk Scores: Integrating Genetics and Multi-Omic Data for Personalised Risk Stratification and Earlier Screening How large international collaborations are improving cardiovascular risk prediction, and the evidence tying overweight and obesity to higher death rates. Talk Thu Jan 28 16:40–17:10 Longitudinal Tracking of Lung Cancer Clonal Dynamics using Circulating Tumour DNA How a method that reads very scarce tumour DNA in the blood tracks lung cancer's evolving cell populations and hints at hidden immunotherapy resistance. |
Wellcome Sanger Institute Hinxton, UK | |
Genomics research institute sequencing and studying genomes in human health, cancer, pathogens and biodiversity. | Talk Wed Jan 27 11:30–12:00 Rethinking Cholera - How Genomics Transformed Our Understanding of a Global Pandemic How genomics overturned old ideas about how cholera spreads and persists, and why tracking it needs global, fairly shared data. Talk Wed Jan 27 12:30–13:00 Pregnancy as a Window into Immune and Disease Biology How repeated RNA sequencing through pregnancy tracks immune changes, and whether pre-eclampsia and preterm birth carry distinct molecular signatures. Talk Wed Jan 27 12:30–13:00 Taking Single Cell mRNA Sequencing to the Bedside How the Human Cell Atlas, which defines cell types by their mRNA, could help bring single-cell mRNA sequencing into clinical care. Talk Wed Jan 27 12:30–13:00 Towards Nucleotide Resolution Genomic Medicine: Scaling MAVEs How lab experiments that test huge numbers of DNA variants at once build function maps for interpreting genetic test results and training AI. Talk Wed Jan 27 15:30–16:00 Cell-Type-Specific Isoform Dysregulation in Crohn's Disease: Insights from Single-Cell Long-Read Sequencing How single-cell long-read sequencing of gut cells finds cell-type-specific splicing in Crohn's disease that may explain puzzling genetic risk regions. Single-cell genomics Talk Wed Jan 27 16:30–17:00 Single-Cell & Spatial to Decode Tissue Biology Through the Lens of Women's Health How single-cell and spatial maps of the ovaries, fallopian tubes and uterus reveal how their cells are organised and improve lab-grown models. Workshop Wed Jan 27 16:30–18:00 Panel Wed Jan 27 17:30–18:00 Choosing the Right Sequencing Technology: Short Reads, Long Reads & Beyond How researchers weigh short-read and long-read sequencing on accuracy, resolution, throughput and cost, and when to combine them. Talk Thu Jan 28 11:30–12:00 Decoding the Tissue Ecosystems of the Human Body How single-cell, spatial and AI methods are building reference maps of the developing human body and revealing how cells form tissue neighbourhoods. Talk Thu Jan 28 16:10–16:40 From Microbiome Data to Live Biotherapeutics: Turning Gut Bacteria into Medicine How gut bacteria linked to how patients respond are developed into living medicines, with recent progress in ulcerative colitis and manufacturing hurdles. |
The Institute of Cancer Research London, UK | |
Cancer research institute and college of the University of London, working in partnership with The Royal Marsden. | Talk Wed Jan 27 12:30–13:00 Direct-to-Patient (DTP) Genetic Testing Pathways: Unlocking Capacity For The NHS Genomic Medicine Service and Genomic Population Health Service How offering genetic tests directly to patients could widen access while easing pressure on NHS genomic services. Talk Wed Jan 27 12:30–13:00 Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study How polygenic risk scores, which add up many small genetic effects, could better target prostate cancer screening and weigh the risk of overdiagnosis. Talk Wed Jan 27 14:30–15:00 MAVEs: Multiplex Assays of Functional Effect: Saying Goodbye To VUSs? How lab assays measuring the effects of thousands of genetic variants at once could settle uncertain variants in cancer genetic testing. Talk Wed Jan 27 14:30–15:00 Mapping the Invasive Tumour: How Spatial Biology is Revealing Cancer's Next Move How spatial biology, which maps cells where they sit in tissue, shows how tumour layout and support cells help cancer invade. Talk Wed Jan 27 15:30–16:00 Exploiting Genome Evolution in Inflammatory Bowel Disease to Prevent Colorectal Cancer How cells with abnormal chromosome numbers spread through the inflamed colon years before visible change, flagging future cancer risk in inflammatory bowel disease. Talk Thu Jan 28 11:30–12:00 Integrating Circulating Tumour DNA into Treating Head and Neck Cancer How testing tumour DNA in the blood can guide head and neck cancer treatment, both curative and palliative, and what challenges remain. |
Francis Crick Institute London, UK | |
Biomedical research institute in London founded by the Medical Research Council, Cancer Research UK, Wellcome and three London universities. | Talk Wed Jan 27 11:30–12:00 Cell Identity, Plasticity and Therapeutic Vulnerabilities in Cancer Why the same cell signals cause different behaviours in different tissues, and how cancer cells' identity shapes their response to targeted drugs. Talk Wed Jan 27 16:30–17:00 4,500 Ancient Genomes: Sequencing Human Evolution Through Time How sequencing thousands of ancient genomes traces human migration, natural selection and changing genetic risk for modern diseases such as coeliac disease. Population & social genomics Talk Wed Jan 27 16:30–17:00 Decoding the Mechanisms Behind Immune Infiltration and Spatial Organisation in Tumours How computational methods map where immune cells gather in colorectal tumours, and why those patterns link to patient outlook and treatment response. Talk Thu Jan 28 09:45–10:00 The Next Breakthrough won't happen in a Silo: Reinventing Life Sciences Partnerships in the Age of AI Why AI and genomics call for closer partnerships between universities, drug companies and hospitals to speed discovery and patient care. AI in drug discovery & diagnosticsBiodata & bioinformatics Workshop Thu Jan 28 11:30–13:00 Agentic AI for Single-Cell Genomics AI in drug discovery & diagnosticsSingle-cell genomics Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics |
Find buyers in spatial biology
Tell us what you sell and we’ll find the people at organizations working on spatial biology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse FoG London 2027 by
Organization type
Topic
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Exhibit hall
Everyone
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction